Frostehav is currently President of Acute Care Therapies at Getinge and a member of its Executive Team, and was Vice President of Critical Care there from 2019 to 2022. Before Getinge she held global leadership roles in product development and digitalization at technology company Semcon, and earlier worked at factory automation company FlexLink. She holds an MSc in Industrial Engineering and Management from Linköping University. Getinge has announced her departure.

“Elin brings extensive international leadership experience from the medical technology industry, with a strong track record in operational execution, commercial development and leading complex organisations,” says Jon Sigurdsson, Chair of Vitrolife Group.